App-Quantinova.ai

Scn5a Gating Pore Current Causes Cardiac Arrhythmias Associated with Dilated Cardiomyopathy

Aurelie Mercier - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

N/A

Peri-operative Atrial Fibrillation (POAF) Complicating Non-cardiothoracic Surgery: A Systematic Review

Karan Bami - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Impact of New Guidelines on Atrial Fibrillation Pattern Classification: The Womens Health Study

Roopinder K Sandhu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Aortic Stiffness Predicts Clinical Outcome and Rate of Aortic Root Growth in Marfan Syndrome

Jami C Levine - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Arterial stiffness

Lorestan

The Electrocardiographic Effects of Intranasal Formulations of a New Calcium Channel Blocker, MSP-2017, are Consistent with a Potential Treatment of Paroxysmal Supraventricular Tachycardia: Results of a Phase I Dose Escalation Study

Archer Broughton - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Etripamil

Health-related Quality of Life in Children with Marfan Syndrome

Danielle Hollenbeck-Pringle - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Marfan syndrome

Lorestan

Early Repolarization and Implantable Cardioverter Defibrillator Events in Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)

Brenda Gerull - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

folitixorin calcium

Neurologic Impact of Left Atrial Appendage Exclusion in Mitral Valve Surgery, a Retrospective Study

Emile Voisine - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Novel Strategy for Improved Substrate Mapping of the Atria: Omnipolar Catheter and Signal Processing Technology Assesses Electrogram Signals Along Physiologic and Anatomic Directions

Ram Balachandran - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Validation of Novel Algorithm to Automate Detection of Fractionated Electrograms During Ventricular Tachycardia (VT) Ablation

Yaariv Khaykin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Results of Research Genetic Testing in Pediatric Cardiomyopathy Patients Justify Broader Clinical Genetic Testing

Steven E. Lipshultz - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

Impact of Diabetes Mellitus on the Prognosis of Patients with Heart Failure and Preserved Left Ventricle Ejection Fraction: Insights From the TOPCAT Study

Brian Harty - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Myocardial infarction

N/A

Impact of the GNB3 C825T Polymorphism on Heart Failure Survival

Karen Hanley-Yanez - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

hydralazine

Usefulness of B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin for Risk Stratification in Low Flow, Low Gradient Aortic Stenosis -A Substudy of the TOPAS Study

Marie-Annick Clavel - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

30-day All-cause Readmission is Associated with a Significantly Higher Subsequent All-cause Mortality and Costly Readmissions Among Older Medicare Beneficiaries Hospitalized for Heart Failure

Rahul Khosla - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Importance of Longitudinal Dyssynchrony in Low Flow Low Gradient Severe Aortic Stenosis Patients Undergoing Dobutamine Stress Echocardiography. A Multicenter Study (on Behalf of the HAVEC Group)

Antonia Delgado-Montero - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Dobutamine

Left Ventricular Myocardial Mechanics at Rest and During Exercise in Children After Arterial Switch Operation

Andreea Dragulescu - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial Dysfunction

N/A

Impact of Aortic Valve Repair and Valve-sparing Procedures on the Mitral Annular Geometry Assessed by 3-dimensional Transesophageal Echocardiography

Hopital du Sacre-Coeur de Montreal - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic regurgitation

N/A

Non-invasive Derivation of Resting Coronary Artery Flow Directly From CT Angiography (CTA) via the Transluminal Attenuation Gradient (TAG) in Left- versus Right-dominant Circulation

Rani Sewatkar - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

Carvedilol

Fast, Free-breathing, Heart-rate Independent Quantitative Myocardial Oxygenation MRI at 3T for Detecting Ischemic Heart Disease without Contrast Agents with Simultaneous 13N-Ammonia PET Validation

Damini Dey - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Adenosine

Filters

28841 Abstracts